Afghanistan: According to the World Trade Organization (WTO) Tariff Database, Afghanistan applies a Most Favored Nation (MFN) tariff rate of 2.5% on products classified under HS code 30049099. As of March 26, 2026, there is no preferential trade agreement between India and Afghanistan that offers a reduced tariff rate for this product category. However, Afghanistan's Ministry of Public Health may grant exemptions or reduced tariffs for essential medicines, including antidandruff treatments, under specific circumstances.
United Kingdom: The United Kingdom's HM Revenue & Customs (HMRC) indicates an MFN tariff rate of 0% for HS code 30049099, reflecting the country's policy of zero tariffs on pharmaceutical products. The UK and India have been negotiating a Free Trade Agreement (FTA), but as of March 26, 2026, no such agreement has been finalized. Essential medicines, including antidandruff products, are typically exempt from tariffs, aligning with the UK's commitment to facilitating access to healthcare products.
Philippines: The Philippines Bureau of Customs applies an MFN tariff rate of 3% on HS code 30049099. Under the ASEAN-India Free Trade Agreement, the Philippines offers a preferential tariff rate of 0% for this product category, benefiting Indian exporters. Essential medicines are often subject to exemptions or reduced tariffs, as per the Department of Health's guidelines, to ensure affordability and accessibility.
United Arab Emirates (UAE): The UAE Federal Customs Authority imposes an MFN tariff rate of 5% on HS code 30049099. While the UAE and India have engaged in trade discussions, no specific FTA covering pharmaceutical products has been implemented as of March 26, 2026. The UAE Ministry of Health and Prevention may provide exemptions or reduced tariffs for essential medicines, including antidandruff treatments, to promote public health.